Daniel Hirschhorn

Keywords immature neutrophils bone metastases DKK1 CHI3L3 cancer immunotherapy Get full text access Log in, subscribe or purchase for full access. References 1. Coleman, R.E. ∙ Croucher, P.I. ∙ Padhani, A.R. ... Bone metastases Nat. Rev. Dis. Primers. 2020; 6:83 2. Siegel, R.L. ∙ Miller, K.D. ∙ Fuchs, H.E. ... Cancer statistics, 2022 CA Cancer J. Clin. 2022; 72:7-33 3. Kim, Y.J. ∙ Kim, S.H. ∙ Kim, J.W. ... Gastric cancer with initial bone metastasis: a distinct group of diseases with poor prognosis Eur. J.

Swim Across America and Ludwig Collaborative Laboratory, Department of Pharmacology, Weill Cornell Medical Center, New York, NY, USA Sandra and Edward Meyer Cancer Center, Weill Cornell Medical Center, New York, NY, USA Department of Medicine, Weill Cornell Medical Center, New York, NY, USA Immunology and Microbial Pathogenesis Program, Weill Cornell Graduate School, New York, NY, USA Parker Institute for Cancer Immunotherapy, Weill Cornell Medicine, New York, NY, USA

The eradication of antigenically heterogeneous tumors by T cell immunotherapies requires neutrophils.